|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Bristol-Myers Squibb |
|---|---|
| Information provided by: | Bristol-Myers Squibb |
| ClinicalTrials.gov Identifier: | NCT00036348 |
Purpose
The purpose of this study is to learn if aripiprazole is effective in the treatment of patients with a history of bipolar disorder.
| Condition | Intervention | Phase |
|---|---|---|
|
Bipolar Disorder |
Drug: Aripiprazole |
Phase III |
| Study Type: | Interventional |
| Study Design: | Treatment |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Patients with a history of Bipolar I Disorder
Contacts and Locations| United States, Alabama | |
| Local Institution | |
| Birmingham, Alabama, United States | |
| Local Institution | |
| Tuscaloosa, Alabama, United States | |
| United States, California | |
| Local Institution | |
| Chillicothe, California, United States | |
| Local Institution | |
| Riverside, California, United States | |
| Local Institution | |
| Torrance, California, United States | |
| Local Institution | |
| Stanford, California, United States | |
| United States, Georgia | |
| Local Institution | |
| Atlanta, Georgia, United States | |
| United States, Illinois | |
| Local Institution | |
| Chicago, Illinois, United States | |
| United States, Kentucky | |
| Local Institution | |
| Louisville, Kentucky, United States | |
| United States, Louisiana | |
| Local Institution | |
| Shreveport, Louisiana, United States | |
| United States, Massachusetts | |
| Local Institution | |
| Belmont, Massachusetts, United States | |
| United States, Nevada | |
| Local Institution | |
| Las Vegas, Nevada, United States | |
| United States, New Mexico | |
| Local Institution | |
| Albuquerque, New Mexico, United States | |
| United States, New York | |
| Local Institution | |
| New York, New York, United States | |
| United States, Pennsylvania | |
| Local Institution | |
| Philadelphia, Pennsylvania, United States | |
| United States, Tennessee | |
| Local Institution | |
| Memphis, Tennessee, United States | |
| Local Institution | |
| Nashville, Tennessee, United States | |
| United States, Texas | |
| Local Institution | |
| San Antonio, Texas, United States | |
| Local Institution | |
| Austin, Texas, United States | |
More Information
| Study ID Numbers: | CN138-010 |
| Study First Received: | May 8, 2002 |
| Last Updated: | June 27, 2008 |
| ClinicalTrials.gov Identifier: | NCT00036348 |
| Health Authority: | United States: Food and Drug Administration |
|
Bipolar I disorder |
|
Affective Disorders, Psychotic Mental Disorders Bipolar Disorder |
Mood Disorders Psychotic Disorders Aripiprazole |
|
Tranquilizing Agents Pathologic Processes Disease Therapeutic Uses Physiological Effects of Drugs |
Psychotropic Drugs Central Nervous System Depressants Antipsychotic Agents Central Nervous System Agents Pharmacologic Actions |
